PAREXEL International Co. (PRXL) Shares Bought by FDx Advisors Inc.
FDx Advisors Inc. increased its stake in PAREXEL International Co. (NASDAQ:PRXL) by 26.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,176 shares of the medical research company’s stock after purchasing an additional 658 shares during the quarter. FDx Advisors Inc.’s holdings in PAREXEL International were worth $280,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Jennison Associates LLC purchased a new position in PAREXEL International in the 3rd quarter worth about $448,000. Harvest Management LLC increased its stake in PAREXEL International by 100.0% in the 3rd quarter. Harvest Management LLC now owns 20,000 shares of the medical research company’s stock worth $1,762,000 after purchasing an additional 10,000 shares in the last quarter. IndexIQ Advisors LLC purchased a new position in PAREXEL International in the 3rd quarter worth about $8,986,000. Gabelli Funds LLC boosted its position in PAREXEL International by 373.7% during the 3rd quarter. Gabelli Funds LLC now owns 320,992 shares of the medical research company’s stock worth $28,273,000 after acquiring an additional 253,224 shares during the period. Finally, State of Wisconsin Investment Board boosted its position in PAREXEL International by 86.2% during the 3rd quarter. State of Wisconsin Investment Board now owns 124,500 shares of the medical research company’s stock worth $10,966,000 after acquiring an additional 57,653 shares during the period. 87.45% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages have commented on PRXL. Zacks Investment Research lowered PAREXEL International from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. BidaskClub lowered PAREXEL International from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $80.76.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/parexel-international-co-prxl-shares-bought-by-fdx-advisors-inc/1719344.html.
Shares of PAREXEL International Co. (PRXL) opened at $88.08 on Wednesday. The company has a quick ratio of 1.45, a current ratio of 1.45 and a debt-to-equity ratio of 1.01. PAREXEL International Co. has a one year low of $51.16 and a one year high of $88.10.
PAREXEL International (NASDAQ:PRXL) last announced its quarterly earnings results on Monday, August 28th. The medical research company reported $1.02 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.94 by $0.08. The business had revenue of $557.20 million for the quarter, compared to analyst estimates of $537.59 million. PAREXEL International had a return on equity of 19.95% and a net margin of 4.62%. During the same quarter in the previous year, the firm earned $0.94 EPS.
PAREXEL International Company Profile
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.
Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PAREXEL International Co. (NASDAQ:PRXL).
Receive News & Ratings for PAREXEL International Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.